C.M. Bidwell & Associates’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-440
Closed -$36.2K 512
2022
Q4
$36.2K Sell
440
-1,914
-81% -$158K 0.03% 317
2022
Q3
$184K Buy
2,354
+1,779
+309% +$142K 0.15% 123
2022
Q2
$39K Buy
+575
New +$40.1K 0.03% 293
2022
Q1
Sell
-55
Closed -$3K 526
2021
Q4
$3K Sell
55
-4,535
-99% -$270K ﹤0.01% 475
2021
Q3
$293K Buy
4,590
+1,010
+28% +$63.8K 0.19% 93
2021
Q2
$225K Buy
3,580
+3,525
+6,409% +$221K 0.15% 127
2021
Q1
$3K Sell
55
-825
-94% -$44.6K ﹤0.01% 468
2020
Q4
$44K Buy
+880
New +$35.1K 0.04% 294
2018
Q3
Sell
-2,355
Closed -$96K 382
2018
Q2
$96K Buy
+2,355
New +$95K 0.09% 192
2017
Q4
Sell
-200
Closed -$10K 389
2017
Q3
$10K Sell
200
-3,945
-95% -$192K 0.02% 208
2017
Q2
$205K Buy
+4,145
New +$184K 0.04% 146

Other funds holding ACHC

C.M. Bidwell & Associates's ACHC Position: Q1 2023 in Review

C.M. Bidwell & Associates sold out of Acadia Healthcare (ACHC) in Q1 2023, closing a stake of 440 shares — an estimated $36.2K sold.

C.M. Bidwell & Associates first reported a position in ACHC in Q2 2017 and held it in 11 quarters. The position peaked at $293K in Q3 2021. 310 funds tracked by Wall St. Rank hold ACHC as of Q1 2023.

  • C.M. Bidwell & Associates reported no remaining Acadia Healthcare position as of Q1 2023 after selling out during the quarter.
  • C.M. Bidwell & Associates sold 440 Acadia Healthcare shares in Q1 2023, an estimated $36.2K.
  • C.M. Bidwell & Associates first reported a position in Acadia Healthcare in Q2 2017 and held it in 11 quarters.
  • C.M. Bidwell & Associates's Acadia Healthcare position peaked at $293K in Q3 2021.
  • 310 funds tracked by Wall St. Rank held Acadia Healthcare as of Q1 2023.

Based on C.M. Bidwell & Associates's 13F filing for Q1 2023, filed 12 May 2023.